1. Market Research
  2. > Biotechnology Market Trends
  3. > Biological Therapy

Biological Therapy Industry: Top Market Reports

  • Currently 5/5 Stars.
  • 1
  • 2
  • 3
  • 4
  • 5
1 vote

Global Biological Therapy Industry

The world biologics industry was worth almost $150 billion in 2010, according to research from BCC Research. The market is expected to record yearly growth of around 10% to reach almost $240 billion by 2015.

Market growth is fuelled by interest in biosimilars, the need to elaborate a superior drug pipeline, a move toward cost-reducing manufacturing technologies and appealing targets against challenging diseases.

Key Market Segments

The global gene therapy market is benefiting from increasing interest in the development of disease treatment. RNCOS notes that this market holds strong development potential as progress in the field of gene therapy facilitates research into the pathogenesis of diseases. This involves a move from research laboratories to clinical trials, which leads to greater potential for the biotechnology sector. Gene therapy market expansion is expected to be very strong over the coming years, fuelled by interest from biopharma companies focused on the area. Companies are expected to elaborate therapies for disease through on-site research and grow acquired therapies into commercial forms.

Gene therapy will prove vital to the medical industry to provide a disease-specific approach to developing treatments. The therapeutic applications of gene therapy are expanding to encompass areas like acquired diseases, including immunodeficiency syndromes. Growth is strong in the US, the EU, China, Japan and Canada. Cancer treatment is expected to represent the fastest-growing segment, followed by infectious diseases such as AIDS.

The global RNA Interference (RNAi) industry is expected to record 28% yearly growth for the five-year period ending 2015, reports RNCOS. Market growth will be fuelled by greater use of the expertise for functional genomics research, necessary for target validation, drug discovery and drug development. 

The worldwide market for cancer therapiesis expected to reach $225 billion by 2017, according to research from Global Industry Analysts. Market expansion will be fuelled by increasing numbers of cancer patients, adoption of new drugs and growing existing drugs. Market growth will also be driven by greater adoption of high-priced biologic therapies in cancer treatment. Medical treatment of cancer includes therapies such as chemotherapy, radiotherapy and gene therapy. The majority of cancer therapies are elaborated using hormones and cytokines, colony stimulating factors, monoclonal antibodies oncolytic viruses, cancer vaccines, antisense oligonucleotides and other approaches.

Leading companies in the sector include Takeda Pharmaceutical Company, GlaxoSmithKline, Eli Lilly, Amgen, Hoffmann-La Roche, Janssen Biotech, Sanofi-Aventis, AstraZeneca, Celgene Corporation, Novartis, Genentech and Bristol-Myers Squibb.

Regional Market Share

The US stem cell market is expected to record yearly growth of 45% between 2011 and 2013, reports RNCOS. The market has recorded strong growth over the past few years with massive investment despite the economic recession. Stem cell technologies and products are giving rise to breakthroughs in the treatment of diseases.

Read more »

Share

You might be interested in these related markets:

24/7 Customer Support

Talk to Sam

+1 718 473 0872

1-10 of about 1 200 reports

Global Biological Therapy Industry - Forecast

  • January 2016
    33 pages
  • Gene Therapy  

    Cell Therapy  

    Stem Cell  

  • World  

View report >

Biological Therapy Industry in the US

  • July 2016
    9 pages
  • Biological Ther...  

  • United States  

View report >

The future of the Biological Therapy Industry in Europe

  • January 2016
    5 pages
  • Biological Ther...  

  • Europe  

View report >

Biological Therapy Industry in Asia and the US

  • January 2016
    9 pages
  • Biological Ther...  

    Cell Therapy  

  • Asia  

    United States  

View report >

Biological Therapy Industry in Japan

  • July 2016
    9 pages
  • Biological Ther...  

    Cytokine  

  • Japan  

View report >

Biological Therapy Industry in France

  • April 2016
    9 pages
  • Biological Ther...  

  • France  

View report >

Biological Therapy Industry in Germany and the US

  • June 2016
    12 pages
  • Biological Ther...  

    Biopharmaceutic...  

    Biotechnology  

  • Germany  

    United States  

View report >

Biological Therapy Industry in the US and Italy

  • January 2015
    7 pages
  • Biological Ther...  

    Cytokine  

  • Italy  

    United States  

View report >

Biological Therapy Industry in the UK

  • July 2016
    8 pages
  • Biological Ther...  

    Cell Therapy  

  • United Kingdom  

View report >

Biological Therapy Industry in Canada

  • July 2016
    9 pages
  • Biological Ther...  

  • Canada  

View report >

Search in Biological Therapy Industry (About 1 200 reports)
Parent industry: Biotechnology
Related industries: Biomaterial, Biopharmaceutical, Genetically Modified Organism, Genomics

About 900 reports

Purchase Reports From Reputable Market Research Publishers
(From $ 75 - $ 42 529)

Retinitis Pigmentosa (Retinitis) - Pipeline Review, H1 2016

Retinitis Pigmentosa (Retinitis) - Pipeline Review, H1 2016

  • $ 42 529
  • Company report
  • June 2016
  • by Global Markets Direct

Retinitis Pigmentosa (Retinitis) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Retinitis Pigmentosa (Retinitis) - Pipeline Review, H1 2016’, provides an overview of the Retinitis Pigmentosa ...

Sangamo Biosciences, Inc. - Product Pipeline Review - 2 ...

June 2016 $ 42 529

Mucopolysaccharidosis Iii (mps Iii) (sanfilippo Syndrom ...

June 2016 $ 42 529

Mucopolysaccharidosis I (mps I) (hurler Syndrome ) - Pi ...

June 2016 $ 42 529

Type 1 Diabetes (juvenile Diabetes) - Pipeline Review, ...

June 2016 $ 42 529

Liver Failure (hepatic Insufficiency) - Pipeline Review ...

June 2016 $ 42 529

Age Related Macular Degeneration - Pipeline Review, H1 ...

May 2016 $ 42 521

Cervical Intraepithelial Neoplasia (cin) - Pipeline Rev ...

May 2016 $ 42 521

Metachromatic Leukodystrophy (mld) - Pipeline Review, H ...

May 2016 $ 42 521

Immuno-oncology Strategic Insight - Multi-indication An ...

May 2016 $ 9 495

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.